Roche Holding | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
AbbVie USD 9.34B 1.36B 2025-03
Alcon AG USD 1.38B 2M 2025-03
Almirall EUR 191.9M 185.49M 2025-03
Amgen USD 6.17B 624M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Bayer EUR 6.38B 1.74B 2025-06
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Fresenius EUR 1.46B 47M 2025-06
Fresenius Medical Care EUR 1.22B 31M 2025-06
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 868M 195M 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 692M 64M 2024-12
Lonza CHF 1.04B 72M 2024-12
Merck EUR 3.03B 118M 2025-06
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Orion EUR 248.3M 46.5M 2025-06
Pfizer USD 10.88B 248M 2025-06
Philips EUR 2.01B 162M 2025-06
Recordati EUR 423.85M 34.92M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12


Roche Holding Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.